Carregant...
Disease activity in axial spondyloarthritis after discontinuation of TNF inhibitors therapy
OBJECTIVE: Use of tumour necrosis factor inhibitors (TNFi) has proved to be an important step forward in the treatment of axial spondyloarthritis (axSpA), but the duration of the therapy as well as the management in case of low disease activity (LDA) or remission are not clearly established. Current...
Guardat en:
| Publicat a: | Reumatologia |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5647530/ https://ncbi.nlm.nih.gov/pubmed/29056769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/reum.2017.69775 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|